Formulation and Drug Delivery

Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery

August 17, 2023

With this agreement, Chiesi Global Rare Diseases will co-develop drug delivery systems with Aliada Therapeutics for large-molecule therapeutics that can cross the blood-brain barrier.

Drug Solutions Podcast: mRNA Past, Present, and Future

August 17, 2023

An mRNA conversation about the recent past, current hot topics, and probable future.

Miniaturing Personalized Cancer Vaccines Through mRNA

August 17, 2023

Experts discuss the promise of personalized cancer vaccines through the inherent nimbleness of mRNA platform.

Sparian Biosciences Awarded Five-Year NIH/NDA Grant for Development of SBS-518

August 09, 2023

SBS-518 is a first-in-class dual sigma receptor (SR) antagonist/dopamine transporter (DAT) inhibitor in development for the treatment of stimulant use disorder (StUD).

Overcoming Challenges to Formulation Development for Pediatric Medicines

August 03, 2023

The biggest hurdle is developing palatable formulations that are efficacious and patient friendly.

Charting the Future of Vaccines

August 03, 2023

A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.

Drug Solutions Podcast: Innovations and Advances in Drug Dosage Forms

August 01, 2023

In this episode, David Tisi and Reenal Gandhi provide expert insights into advances and innovations changing the drug dosage form landscape.

Teva Pharmaceuticals and Alvotech Expand Existing Biosimilars Partnership

July 27, 2023

Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.

EMA Gives Positive Opinion on Two of Janssen’s Bispecific Antibodies

July 27, 2023

Janssen has received a positive opinion from the EMA for two novel bispecific antibodies, TALVEY (talquetamab) and TECVAYLI (teclistamab), which the company is developing to treat blood cancer.

Drug Solutions Podcast: Evaluating the Vaccine Marketplace

July 18, 2023

Jeff Fischer, co-founder and president of Longhorn Vaccines and Diagnostics, discusses the history and ongoing development of both protein- and mRNA-based vaccines.